Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis

Phase 2

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: PF-04171327
Other: placebo
Other: prednisone

First Posted Date: 2011-07-13

Last Posted Date: 2018-12-14

Lead Sponsor: Pfizer

Target Recruit Count: 323

Registration Number: NCT01393639

Locations: 🇧🇬
Revmatologichno Otdelenie, MBAL - Plovdiv, Plovdiv, Bulgaria
🇧🇬
MBAL "Sveti Ivan Rilski" Sofia; Klinika po Revmatologia, Sofia, Bulgaria
🇲🇽
Centro de Estudios de Investigacion Basica y Clinica SC., Guadalajara, Jalisco, Mexico

and more 88 locations

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Phase 2

Completed

Conditions: Crohn's Disease

Interventions: Drug: Placebo
Drug: CP-690,550

First Posted Date: 2011-07-13

Last Posted Date: 2017-04-28

Lead Sponsor: Pfizer

Target Recruit Count: 280

Registration Number: NCT01393626

Locations: 🇺🇸
Alliance Clinical Research, Oceanside, California, United States
🇺🇸
Endoscopy Center of Connecticut, LLC, Hamden, Connecticut, United States
🇺🇸
Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States

and more 133 locations

Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: PF-05105679

First Posted Date: 2011-07-13

Last Posted Date: 2011-10-03

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT01393652

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

Phase 2

Completed

Conditions: Crohn's Disease

Interventions: Drug: Placebo
Drug: CP-690,550

First Posted Date: 2011-07-13

Last Posted Date: 2017-01-09

Lead Sponsor: Pfizer

Target Recruit Count: 180

Registration Number: NCT01393899

Locations: 🇦🇺
Monash Medical Centre, Clayton, Victoria, Australia
🇭🇺
Pannonia Magánorvosi Centrum Kft, Budapest, Hungary
🇭🇺
Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak/I. Belgyogyaszat es Gastroenterologia, Budapest, Hungary

and more 88 locations

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

Phase 4

Completed

Conditions: Pneumococcal Vaccines

Interventions: Biological: 13-valent pneumococcal conjugate vaccine
Biological: INFANRIX hexa
Drug: Paracetamol
Drug: Ibuprofen

First Posted Date: 2011-07-12

Last Posted Date: 2014-02-26

Lead Sponsor: Pfizer

Target Recruit Count: 908

Registration Number: NCT01392378

Locations: 🇵🇱
NZOZ Praktyka Lekarza Rodzinnego Eskulap, Lublin, Poland
🇵🇱
NZOZ Nasz Lekarz, Torun, Poland
🇵🇱
DEN-MED Gabinet Lekarsko-Stomatologiczny Joanna i Jacek Witwiccy, Warszawa, Poland

and more 11 locations

Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Treatment A
Drug: Treatment B

First Posted Date: 2011-07-07

Last Posted Date: 2011-08-10

Lead Sponsor: Pfizer

Target Recruit Count: 10

Registration Number: NCT01388829

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Phase 2

Completed

Conditions: Aspergillosis, Aspergilloma

Interventions: Drug: Voriconazole

First Posted Date: 2011-06-28

Last Posted Date: 2014-05-09

Lead Sponsor: Pfizer

Target Recruit Count: 21

Registration Number: NCT01383993

Locations: 🇯🇵
Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Aichi, Japan
🇯🇵
Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan
🇯🇵
Sapporo Hokuyu Hosipital, Sapporo, Hokkaido, Japan

and more 3 locations

Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users

Phase 1

Completed

Conditions: Nondependent Opioid Abuse, Episodic

Interventions: Drug: Placebo
Drug: MS Contin (morphine sulfate, controlled release)
Drug: EMBEDA (morphine sulfate / naltrexone hydrochloride)

First Posted Date: 2011-06-27

Last Posted Date: 2012-05-31

Lead Sponsor: Pfizer

Target Recruit Count: 80

Registration Number: NCT01380093

Locations: 🇺🇸
Lifetree Clinical Research, Salt Lake City, Utah, United States

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Tofacitinib

First Posted Date: 2011-06-17

Last Posted Date: 2013-10-29

Lead Sponsor: Pfizer

Target Recruit Count: 83

Registration Number: NCT01375127

Locations: 🇪🇸
Pfizer Investigational Site, Barcelona, Spain

Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

Phase 1

Completed

Conditions: Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)

Interventions: Drug: Bosutinib

First Posted Date: 2011-06-15

Last Posted Date: 2011-11-30

Lead Sponsor: Pfizer

Target Recruit Count: 88

Registration Number: NCT01374139

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy